Cathie Wood’s ARK buys 220,000 Circle shares for $13.9M
ARK Invest bought 220,000 Circle shares across three ETFs on Tuesday for about $13.9 million, raising July disclosed purchases to 725,517 as the stock is down 22% year-to-date.
ARK Invest purchased 220,000 shares of Circle Internet Group (CRCL) across three actively managed exchange-traded funds on Tuesday, paying the New York Stock Exchange closing price of $63.22 per share for a total of about $13.9 million.
The latest trade brings ARK’s publicly disclosed July acquisitions of Circle shares to 725,517. Earlier reported purchases in the month included 287,609 shares on July 1 and 217,896 shares on July 9.
Holdings data show Circle represented 4.37% of the ARK Fintech Innovation ETF (ARKF), the fund’s seventh-largest holding and valued at about $33 million. In the ARK Innovation ETF (ARKK), Circle accounted for 3.35% of assets and ranked ninth, with a value near $218 million.
Circle’s stock has fallen about 22% year-to-date and is roughly 76% below its post-IPO peak.
In a report published Tuesday, digital asset research firm 10x Research said it no longer considers Circle a buy after the stock dropped below $80. The report cited a deterioration in Circle’s fundamentals and slower activity for the USDC stablecoin, including a decline in active addresses.
USDC’s market capitalization has slipped about 3% year-to-date to roughly $73 billion, while remaining about 17% larger than a year earlier.
ARK’s daily trade disclosures show the firm added to its Circle position multiple times in July. The filings list the transactions, the funds involved and the current fund-weight figures for Circle.
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.







